Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Sep 6;21(5):1178–1187.e1. doi: 10.1016/j.cgh.2022.08.030

Table 2.

VA-AC Baseline Characteristics from 10/1999 to 12/2020

Variable Achalasia Subjects (n = 2,100)
Age, median (IQR) 65 (57–72)
Sex
 Male, n (%) 1949 (92.8)
 Female, n (%) 151 (7.2)
Ethnicity
 Hispanic, n (%) 142 (6.8)
 Non-Hispanic, n (%) 1908 (90.9)
 Unknown, n (%) 50 (2.4)
Race
 Asian, n (%) 14 (0.7)
 Black, n (%) 420 (20.0)
 Other, n (%) 9 (0.4)
 Pacific Islander, n (%) 16 (0.8)
 White, n (%) 1504 (71.6)
 Unknown, n (%) 137 (6.5)
BMI, median (IQR) 28.3 (24.9–32.3)
Smoking Status
 Current, n (%) 646 (30.8)
 Former, n (%) 531 (25.3)
 Never, n (%) 722 (34.4)
 Unknown, n (%) 201 (9.6)
Aspirin Exposure
 Yes, n (%) 814 (38.8)
Diabetes
 Yes, n (%) 735 (35.0)
Candida Esophagitis
 Yes, n (%) 78 (3.7)
Barrett’s Esophagus
 Yes, n (%) 95 (4.5)

IQR = interquartile range; BMI = body mass index